A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)

NCT02460159 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Heterozygous Familial Hypercholesterolemia

Interventions

DRUG: EZ 10 mg/Atorva 20 mg FDC
DRUG: EZ 10 mg/Atorva 10 mg FDC

Sponsor

Organon and Co